Back to top
more

Invesco Biotechnology & Genome ETF: (PBE)

(Delayed Data from NYSE) As of May 9, 2024 03:47 PM ET

$64.16 USD

64.16
3,114

+0.41 (0.64%)

Volume: 3,114

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

3 - Hold of 5     3    

After-Market: $64.12 -0.04 (-0.06 %) 7:58 PM ET

ETF Quote Details

Previous Close 63.75
Open 63.97
Bid 60.93
Ask 67.62
Day Low-High 63.34-64.16
52wk Low-High 52.47-67.76
Volume 3,114
NAV (month end) 60.84
Premium (+)/Discount (-) (month end)+2.91

Zacks Premium Research for PBE

Zacks ETF Rank

This is our ETF rating system that serves as a timeliness indicator for ETFs over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

See all the Top Ranked ETFs here - The complete list of all the top ranked ETFs

 Hold 3
ETF Risk

Zacks proprietary quantitative models divide each set of ETFs following a similar investment strategy (style box/industry/asset class) into three risk categories- High, Medium, and Low. The aim of our models is to select the best ETFs within each risk category, so that investors can pick an ETF that matches their particular risk preference in order to better achieve their investment goals.

High
ETF Research Report

ETF Expense Ratio

Expense Ratio 0.58%
Dividend (Yield) $0.04 (0.06%)
Issuer INVESCO

Benchmark for PBE

DYNAMIC BIOTECH & GENOME INTELLIDEX INDX

The Dynamic Biotech & Genome Intellidex Index seeks to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value.

Fund Summary for PBE

INVESCO BIOTECHNOLOGY & GENOME ETF

The Invesco Biotechnology & Genome ETF seeks to track the Dynamic Biotech & Genome Intellidex Index.